ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 53327 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 53327; 2) Community: the network communities that were significantly associated with the response to NSC 53327; 3) Molecule: the relationships between components within communities and NSC 53327; 4) MDR: the compounds that were significantly associated with the NSC 53327.

NSC Compound Enrichment Correlation
NSC 735001 Null 0.0273093708703115 0.23390483
NSC 740844 Null 0.0273093708703115 0.16507149
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0273093708703115 0.22571096
NSC 753601 Null 0.0273093708703115 0.16168163
NSC 81260 Celliton Fast Violet B 0.0273093708703115 0.10534499
NSC 85700 Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) 0.0273093708703115 0.26720873
NSC 118218 2-Fluoro Ara A 0.0287337488682928 0.093981703
NSC 19441 FDA 0283 0.0287337488682928 0.23260051
NSC 646112 Null 0.0287337488682932 0.28361347
NSC 676792 Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl)]-.beta.-D-xylopyranosyl] ester 0.0287337488682932 -0.09519394
Total:72  Current:47    [First] [Prev] [Next] [Last]